EGFRvIII : molecular insights and therapeutic potential
Barry Jutten(Maastricht University)
Cited by 0
Related Papers
Binding of cetuximab to the EGFRvIII deletion mutant and its biological consequences in malignant glioma cells
|Radiotherapy and Oncology|2009|47